Jones Day

Anthony M. Insogna

Current View:

This content is provided by Anthony M. Insogna.


Anthony Insogna leads Jones Day’s global IP Practice—220 professionals handling IP litigation, technology-driven transactions, and patent and trademark strategy for the world’s top-tier innovators and brands. A leading pharmaceutical and biotech patent attorney in his own right, Anthony regularly develops strategies for, litigates, and conducts portfolio diligence for clinical candidates and FDA-approved products. His experience includes Hatch-Waxman and PTAB litigation for innovators, and handling cutting-edge technologies including, e.g., immune oncology drugs, CRISPR (gene editing), gene therapy, and vaccines. Anthony’s representations include Celgene, a client since 1996, and Bristol-Myers Squibb, Celgene’s parent after those two global companies merged in 2019.